Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by ...

Eli Lilly has hit $1 trillion in market value, making it the first drugmaker to enter the exclusive club dominated by tech ...

Eli Lilly has made history by becoming the first healthcare company to reach a $1 trillion market cap, thanks to the success ...

Eli Lilly becomes the first healthcare firm to hit $1T, powered by GLP-1 dominance, surging sales, and strong investor ...

Eli Lilly hit a $1 trillion valuation for the first time, becoming the only healthcare company to reach the milestone as ...

With the strength of sales in GLP-1 weight loss drugs Mounjaro and Zepbound, Eli Lilly is now the first pharmaceutical ...

Dow Jones Top Company Headlines at 11 AM ET: Eli Lilly Touches $1 Trillion Market Cap on Booming Weight-Loss Drugs | Paramount, ... Lilly becomes the first pharmaceutical company to hit that threshold ...

Eli Lilly reached $1 trillion in market value on Friday, with shares briefly touching an all-time high of $1,060, and becoming the first pharmaceutical company to ever achieve this milestone.

Wall Street projects the global weight-loss drug market could reach $150 billion by 2030, with Lilly and Novo Nordisk ...

Eli Lilly briefly crossed the $1 trillion market cap threshold, the first drug maker to ever reach that milestone.

Separately, companies, including digital health firm Waltz Health and cardiometabolic care provider 9amHealth announced ...

Eli Lilly hit a $1 trillion valuation, driven by demand for Zepbound and Mounjaro. The first health-care firm ever to join ...